Nootropic Sunifiram Powder CAS 314728-85-3 for Memory Enhancement
Produktdetails:
| Name |
Sunifiram |
| Systematic (IUPAC) Name |
1-benzoyl-4-propanoylpiperazine |
| CAS-Nummer |
314728-85-3 |
| Formel |
C14H18N2O2 |
| Aussehen |
weißes Puder |
| Anwendung |
a piperazine derived research chemical which has nootropic effects |
| Aktie |
bulk in stock |
| Assay |
99% |
Sunifiram Description:
Sunifiram (DM-235) is a piperazine derived ampakine drug which acts as a positive allosteric modulator of AMPA receptors, and has nootropic effects in animal studies with significantly higher potency than piracetam. A number of related compounds are known, the best known being unifiram (DM-232).
This enhancement by sunifiram is associated with an increase inphosphorylation of AMPAR through activation of protein kinase II(CaMKII) and an increase in phosphorylation of NMDAR through activation of protein kinase C α (PKCα). Genauer, sunifiram stimulates the glycine-binding site of NMDAR with concomitant PKCαactivation through Src kinase. Enhancement of PKCα activity triggers to potentiate hippocampal LTP through CaMKII activation.Sunifiram improves cognitive deficits via CaM kinase II andprotein kinase C activation.
Related Products
| Name |
CAS-Nr. |
| SR-9009 |
1165910-22-4 |
| Rad-140 |
1182367-47-0 |
| MK-677 |
159752-10-0 |
| YK-11 |
431579-34-9 |
| LGD-4033 |
1165910-22-4 |
| GW-501516 |
317318-70-0 |
| Andarine S4 |
401900-40-1 |
| MK-2866 |
841205-47-8 |
| Sunifiram |
314728-85-3 |
Verkaufsleiter